<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intraoperative fluid management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intraoperative fluid management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intraoperative fluid management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael F O'Connor, MD, FCCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1017038123"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Perioperative maintenance of adequate intravascular volume status is important to achieve optimal outcomes after surgery, but there are controversies regarding optimal composition and volume of intraoperative fluid therapy. This topic will review derangements and monitoring of intravascular volume status in this setting, as well as strategies for choosing appropriate composition, amount, and timing of intraoperative fluid administration.</p><p>Severe intravascular volume depletion in surgical patients is discussed in other topics. (See  <a class="medical medical_review" href="/d/html/94164.html" rel="external">"Intraoperative management of shock in adults", section on 'Hypovolemic shock management'</a> and  <a class="medical medical_review" href="/d/html/7931.html" rel="external">"Massive blood transfusion"</a>.)</p><p>Routine management of maintenance and replacement fluids in nonsurgical settings is discussed separately. (See  <a class="medical medical_review" href="/d/html/2296.html" rel="external">"Maintenance and replacement fluid therapy in adults"</a>.)</p><p class="headingAnchor" id="H254314205"><span class="h1">CAUSES AND CONSEQUENCES OF INTRAVASCULAR VOLUME DERANGEMENTS</span><span class="headingEndMark"> — </span>Normovolemia/euvolemia should be maintained throughout the perioperative period to maintain adequate tissue perfusion. Both hypovolemia and hypervolemia are associated with postoperative morbidity [<a href="#rid1">1-4</a>].</p><p class="headingAnchor" id="H3584705137"><span class="h2">Hypovolemia</span></p><p class="headingAnchor" id="H2529061385"><span class="h3">Causes</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative factors</strong> – Preoperative hypovolemia may increase the risk of significant decreases in blood pressure during induction of anesthesia [<a href="#rid5">5</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Although preoperative fasting overnight for approximately 10 hours does not significantly reduce intravascular volume [<a href="#rid6">6,7</a>], the fasting period is limited to avoid preoperative dehydration [<a href="#rid8">8</a>]. Patients are encouraged to consume clear oral liquids up to two hours before surgery. (See  <a class="medical medical_review" href="/d/html/15698.html" rel="external">"Preoperative fasting in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mechanical bowel preparation is associated with fluid loss from the gastrointestinal tract, which may reduce preoperative intravascular volume. Newer bowel preparations are designed to minimize this loss. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disorders such as bowel obstruction or pancreatitis may cause intravascular volume loss due to inflammation and interstitial edema. (See  <a class="medical medical_review" href="/d/html/2298.html" rel="external">"Etiology, clinical manifestations, and diagnosis of volume depletion in adults", section on 'Etiology'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ongoing bleeding typically requires surgical hemostasis to allow adequate volume repletion. (See  <a class="medical medical_review" href="/d/html/127887.html" rel="external">"Approach to shock in the adult trauma patient"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgery-related factors</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Surgical bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Coagulopathy due to hemodilution and/or hypothermia, which aggravates blood loss</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased venous return due to:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Abdominal insufflation during laparoscopy - (See  <a class="medical medical_review" href="/d/html/100120.html" rel="external">"Anesthesia for laparoscopic and abdominal robotic surgery in adults", section on 'Hemodynamic complications'</a>.)  </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Compression of the inferior vena cava (eg, in the supine position during pregnancy) or other major veins (eg, portal vein) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive pressure mechanical ventilation with large tidal volumes, high positive end-expiratory pressure, or lung recruitment maneuvers to reverse atelectasis. (See  <a class="medical medical_review" href="/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Recruitment maneuvers'</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged duration of surgery with evaporation and insensible fluid loss from exposed body cavities or wounds, particularly with an open abdominal cavity resulting in bowel edema and sequestration of fluid in tissues [<a href="#rid9">9</a>]. Conversely, minimal fluid losses occur during short less invasive surgical procedures [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Any other factors preventing early transition (within 24 hours of surgery) from intravenous (IV) to oral fluid therapy [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H4089253919"><span class="h3">Consequences</span><span class="headingEndMark"> — </span>Hypovolemia results in reduced cardiac output and tissue perfusion. Persistent hypovolemia can lead to shock and multiorgan failure [<a href="#rid11">11,12</a>].</p><p class="headingAnchor" id="H88366188"><span class="h2">Hypervolemia</span></p><p class="headingAnchor" id="H1203209217"><span class="h3">Causes</span><span class="headingEndMark"> — </span>Development of hypervolemia is generally due to excessive volume administration. In many cases, intraoperative fluid is administered to treat hemodynamic instability due to vasodilation, surgical bleeding, myocardial dysfunction, or vascular permeability. This often results in postoperative fluid overload.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthesia-related factors</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>General anesthetic agents – Most IV and inhalation anesthetic and adjuvant drugs including opioids cause dose-dependent vasodilation and myocardial depression that may lead to hypotension that is treated with fluid administration [<a href="#rid13">13,14</a>]. Unnecessarily deep anesthesia with hypotension may lead to excessive fluid administration. (See  <a class="medical medical_review" href="/d/html/94532.html" rel="external">"Hemodynamic management during anesthesia in adults", section on 'Selection and dosing of anesthetic agents'</a>.) </p><p></p><p class="bulletIndent2">Hypotension that persists after reducing anesthetic depth (if appropriate), administration of appropriate amounts of fluid to replace surgical losses, and exclusion of other causes of hypotension should be treated with IV vasopressor/inotropic agents such as <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a>  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>) rather than continuing administration of large amounts of fluid alone. (See <a class="local">'Restrictive (zero-balance) strategy'</a> below and  <a class="medical medical_review" href="/d/html/141346.html" rel="external">"Intraoperative use of vasoactive agents", section on 'Vasopressor and positive inotropic agents'</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neuraxial anesthesia – Sympathetic blockade during neuraxial anesthesia increases venous capacitance and dilates arteriolar resistance vessels, with resultant hypotension. However, rather than preloading with IV fluid to prevent hypotension, we use a vasopressor such as <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a>  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 1</a>).  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgery-related factors</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treatment of surgical bleeding – Excessive administration of crystalloid or colloid together with transfusion of red blood cells results in dilution of coagulation factors, which may exacerbate bleeding and lead to additional transfusions and administration of fluid.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient-related factors</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congestive heart failure (CHF) with compensatory fluid retention</p><p class="bulletIndent2"><span class="glyph">•</span>Renal insufficiency, particularly if renal replacement therapy is inadequate </p><p></p><p class="headingAnchor" id="H1826544250"><span class="h3">Consequences</span><span class="headingEndMark"> — </span>Hypervolemia can result in reduced tissue perfusion due to tissue edema, with clinically significant postoperative fluid retention (ie, weight gain &gt;10 percent above preoperative baseline). Postoperative fluid overload is associated with increased morbidity, length of stay in the intensive care unit, and mortality [<a href="#rid15">15</a>]. Specific systemic effects include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory effects</strong> – Increased extravascular fluid in lung tissue impairs oxygen exchange and increases risk for postoperative respiratory failure and pneumonia [<a href="#rid16">16</a>]. Some patients develop frank pulmonary edema, particularly those with a history of heart failure [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/4401.html" rel="external">"Overview of the management of postoperative pulmonary complications", section on 'Pulmonary edema'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal effects</strong> – Increased extracellular fluid in the bowel can lead sequentially to gastrointestinal edema, decreased gastrointestinal motility, and possibly ileus [<a href="#rid18">18</a>]. In patients undergoing bowel surgery, intestinal edema can increase tension at bowel anastomoses contributing to anastomotic dehiscence [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">Occasionally, massive fluid resuscitation is associated with acute ascites [<a href="#rid19">19</a>]. Ascites and bowel edema can contribute to development of abdominal compartment syndrome [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/2889.html" rel="external">"Abdominal compartment syndrome in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effects on hemostasis</strong> – Excess intravascular fluid dilutes clotting factors, which can contribute to or cause coagulation abnormalities. (See  <a class="medical medical_review" href="/d/html/7931.html" rel="external">"Massive blood transfusion", section on 'Dilutional coagulopathy'</a> and  <a class="medical medical_review" href="/d/html/15147.html" rel="external">"Etiology and diagnosis of coagulopathy in trauma patients", section on 'Resuscitation-associated coagulopathy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effects on wound healing</strong> – Marked tissue edema impairs wound healing. (See  <a class="medical medical_review" href="/d/html/15080.html" rel="external">"Basic principles of wound healing"</a>.)</p><p></p><p class="headingAnchor" id="H254311231"><span class="h1">MONITORING INTRAVASCULAR VOLUME STATUS</span></p><p class="headingAnchor" id="H1166677239"><span class="h2">Intraoperative monitoring challenges</span><span class="headingEndMark"> — </span>Intravascular fluid status is monitored to maintain euvolemia with adequate tissue perfusion. Standard hemodynamic monitors include noninvasive blood pressure (BP) cuff and heart rate (HR) monitoring. In selected cases, one or more invasive monitors of dynamic hemodynamic parameters may be used to predict fluid responsiveness (ie, an increase in stroke volume [SV] and cardiac output [CO] following intravenous fluid administration  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a>)) [<a href="#rid21">21</a>].</p><p>Challenges in estimating intravascular volume status during the intraoperative period include:</p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative volume status may be suboptimal or unknown.</p><p class="bulletIndent1"><span class="glyph">●</span>Surgical volume losses may be continuously changing, but are difficult to quantify.</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular responses to anesthetic agents and dosing are occurring.</p><p class="bulletIndent1"><span class="glyph">●</span>Measured laboratory values do not reflect contemporaneous changes in intravascular volume status.</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical methods routinely used to assess volume status in awake patients (eg, thirst, postural dizziness, lethargy, confusion) are unavailable in the anesthetized patient. </p><p></p><p class="headingAnchor" id="H1307207319"><span class="h2">Traditional static parameters</span><span class="headingEndMark"> — </span>Static parameters (eg, measurements of BP, HR, urine output [UO], central venous pressure [CVP]) have been traditionally used to provide supplemental data regarding intravascular volume status (see  <a class="medical medical_review" href="/d/html/100067.html" rel="external">"Basic patient monitoring during anesthesia", section on 'Monitoring modalities'</a>). However, sole use of these parameters to guide fluid therapy may result in either hypovolemia or hypervolemia. Even with continuous monitoring of these static parameters, significant intraoperative reduction in tissue perfusion may not be recognized [<a href="#rid11">11,12,22</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood pressure and heart rate</strong> – BP and HR responses to changes in intravascular volume status are not predictable in individual patients. Examples include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There is no correlation between BP and CO in patients undergoing major abdominal surgery [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Healthy young patients with subclinical hypovolemia often have normal BP and HR because the stress response to surgery activates the sympathetic nervous system and the renin-angiotensin system, with release of vasoconstrictor hormones that increase BP. Although the resulting peripheral vasoconstriction favors maintenance of adequate perfusion to the heart and the brain, perfusion to other organs (eg, kidneys, gastrointestinal tract, skin) are reduced. Notably, general or neuraxial anesthesia may blunt these compensatory vasoconstrictive responses to decreased perfusion.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients treated with beta-blockers may not manifest tachycardia as a compensatory response to hypovolemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central venous pressure</strong> – CVP measured from a central venous catheter (CVC) or pulmonary artery occlusion pressure (PAOP) measured from a pulmonary artery catheter (PAC) are sometimes used to provide supplemental data regarding intravascular volume status, but these parameters are inaccurate surrogates to determine cardiac preload, fluid responsiveness [<a href="#rid24">24</a>], or impending pulmonary edema [<a href="#rid17">17,21,25-31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urine output </strong>– Oliguria (UO &lt;0.5 mL/kg per hour) is a commonly used indicator of hypovolemia. However, oliguria alone is not a sufficient indication for fluid administration in patients undergoing anesthesia and surgery. For example, inhalation anesthetics, as well as surgical stress, may reduce UO in patients who are actually euvolemic, leading to fluid overload if fluid is administered to treat oliguria [<a href="#rid13">13,14</a>].</p><p></p><p class="bulletIndent1">Notably, intraoperative oliguria does not predict acute kidney injury (AKI) [<a href="#rid4">4</a>]. Data suggest that traditional targets that attempt to continuously maintain UO &gt;0.5 mL/kg per hour are not warranted, although sustained oliguria may be associated with increased risk of renal injury, particularly if &lt;0.3 mL/kg per hour [<a href="#rid32">32-37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mixed venous oxygen saturation </strong>– Measurements intended to track global oxygen (O<sub>2</sub>) delivery have limited utility to guide fluid therapy [<a href="#rid38">38</a>]. These include measurements of mixed venous O<sub>2</sub> saturation from a PAC (SvO<sub>2</sub>) or central venous O<sub>2</sub> saturation (ScvO<sub>2</sub>) from a CVC. Although SvO<sub>2</sub> and ScvO<sub>2</sub> are proportional to CO, tissue perfusion, and tissue O<sub>2</sub> delivery, these measurements are also inversely proportional to tissue O<sub>2</sub> consumption. Thus, values do not reflect changes in tissue perfusion during the perioperative period when O<sub>2</sub> consumption is variable [<a href="#rid38">38,39</a>]. (See  <a class="medical medical_review" href="/d/html/1623.html" rel="external">"Oxygen delivery and consumption"</a>.)</p><p></p><p class="headingAnchor" id="H254311286"><span class="h2">Dynamic parameters to assess volume responsiveness</span><span class="headingEndMark"> — </span>Dynamic hemodynamic indices are used to assess fluid responsiveness and guide goal-directed fluid therapy in patients undergoing major invasive surgery, particularly for procedures with large expected blood losses or fluid shifts [<a href="#rid8">8</a>]. Compared with traditional static parameters, dynamic parameters provide superior assessment of response to a fluid challenge (ie, volume responsiveness) [<a href="#rid26">26,38,40-45</a>]. (See <a class="local">'Goal-directed fluid therapy'</a> below.)</p><p>The following parameters are examples:</p><p class="headingAnchor" id="H1396549197"><span class="h3">Respiratory variations in arterial pressure waveform</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Measured variables</strong> – Variations in the intra-arterial pressure waveform that occur during respiration can be observed or measured to assess responses to fluid challenges  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a>) [<a href="#rid44">44-49</a>]. These include pulse pressure variation (PPV), SV variation (SVV), systolic blood pressure variation (SPV), or change in inferior vena cava diameter. These variations occur during controlled mechanical ventilation because inspiration increases intrathoracic pressure, which reduces venous return, right ventricular (RV) filling volume, and SV. The opposite effects occur during expiration. If arterial vasomotor tone and cardiac function remain constant. these changes in venous return and SV create variations in pulse pressure and systolic BP  (<a class="graphic graphic_figure graphicRef85848" href="/d/graphic/85848.html" rel="external">figure 2</a>) [<a href="#rid48">48</a>]. Normal respiratory variations in these dynamic parameters are &lt;10 percent [<a href="#rid50">50</a>]. Greater variations suggest fluid responsiveness and the likely need for fluid administration  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a>) [<a href="#rid24">24</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limitations</strong> – Each of the dynamic indices based on respiratory variation has advantages and disadvantages  (<a class="graphic graphic_table graphicRef85850" href="/d/graphic/85850.html" rel="external">table 2</a>) [<a href="#rid51">51-53</a>]. Although generally superior to static parameters for assessment of fluid responsiveness (see <a class="local">'Traditional static parameters'</a> above), these dynamic indices may not be useful in certain situations such as [<a href="#rid45">45</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>During spontaneous ventilation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>During mechanical ventilation with low tidal volumes &lt;8 mL/kg or high positive end-expiratory pressure &gt;15 cm H<sub>2</sub>O [<a href="#rid54">54</a>] </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>During open chest procedures [<a href="#rid55">55,56</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with clinical abnormalities such as elevated intra-abdominal pressure, cardiac tamponade, significant auto-PEEP, nonsinus rhythm or other cardiac arrhythmias, right heart failure, or a requirement for vasoactive infusions [<a href="#rid49">49,54,57</a>]</p><p></p><p class="bulletIndent1">Also, there are limitations in sensitivity and specificity. A 2018 systematic review calculated the pooled area under the curve (AUC) for PPV and for SVV (5017 patients; 68 studies) [<a href="#rid53">53</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For PPV, AUC was 0.86 (95% CI 0.80-0.92), with a sensitivity of 80 percent (95% CI 74-85 percent) and specificity of 83 percent (95% CI 73-91 percent) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For SVV, AUC was 0.87 (95% CI 0.81-0.93), with a sensitivity of 82 percent (95% CI 75-89 percent) and specificity of 77 percent (95% CI 71-82 percent)</p><p></p><p class="bulletIndent1">Thus, indices based on respiratory variations are interpreted with caution and should consider the clinical setting and clinical data such as the physical examination and static parameters such as filling pressures, UO, or SvO<sub>2</sub> or ScvO<sub>2</sub> [<a href="#rid45">45</a>]. (See <a class="local">'Traditional static parameters'</a> above.)</p><p></p><p class="bulletIndent1">Notably, although hemodynamic indices of respiratory variation can be computed (manually or automatically), visual estimation is often adequate to guide fluid therapy [<a href="#rid45">45,46</a>]. In one study, determination of the need for a fluid bolus based on visual estimation of SPV in the intra-arterial waveform was compared with computed values; only 1 percent of treatment decisions were incorrect when based solely on visual estimation  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a>) [<a href="#rid46">46</a>].</p><p></p><p>Changes in mean arterial pressure and/or SV induced by lung recruitment maneuvers (eg, ventilation with positive pressure held at 30 cm H<sub>2</sub>O for 30 seconds) can also be used to predict volume responsiveness [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H2813205602"><span class="h3">Ultrasound technologies</span></p><p class="headingAnchor" id="H1964070380"><span class="h4">Esophageal doppler technology</span><span class="headingEndMark"> — </span>Esophageal Doppler devices use a flexible transesophageal Doppler ultrasound probe to measure blood flow velocity in the descending thoracic aorta to derive estimates of SV [<a href="#rid44">44,59,60</a>]. Such devices may be useful when indices based on respiratory variation in the intra-arterial waveform cannot be used. (See <a class="local">'Respiratory variations in arterial pressure waveform'</a> above.)</p><p class="headingAnchor" id="H2075773073"><span class="h4">Echocardiography</span><span class="headingEndMark"> — </span>Left ventricular (LV) size and intravascular volume status can be quickly estimated using transesophageal echocardiography (TEE) or transthoracic echocardiography (TTE). This is typically accomplished in the transgastric midpapillary short-axis view by qualitative visual assessment of LV cavity size. Underfilling of the left ventricle caused by acute hypovolemia is easily recognized in a patient with hyperdynamic systolic function and decreased end-diastolic and end-systolic LV cavity dimensions  (<a class="graphic graphic_movie graphicRef104149" href="/d/graphic/104149.html" rel="external">movie 1</a>). Quantitative measurements of the internal diameter or cross-sectional area of the LV at end-diastole can also be made  (<a class="graphic graphic_diagnosticimage graphicRef109236" href="/d/graphic/109236.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef104503" href="/d/graphic/104503.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef106967" href="/d/graphic/106967.html" rel="external">table 3</a>) [<a href="#rid61">61,62</a>]. Changes from baseline (normovolemia) are monitored using these qualitative and/or quantitative assessments. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Assessment of left ventricular volume'</a>.)</p><p>Point-of-care ultrasound (POCUS) transthoracic echocardiography can also be used to assess left and right atrial and ventricular chambers to estimate intravascular volume status [<a href="#rid63">63</a>]. One study noted good correlation between pulse pressure variation (PPV) during the respiratory cycle and the collapsibility index and distensibility index of the inferior vena cava measured using transthoracic echocardiography during mechanical ventilation [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/d/html/94583.html" rel="external">"Overview of perioperative uses of ultrasound", section on 'Point-of care ultrasound (POCUS)'</a>.) </p><p class="headingAnchor" id="H723561007"><span class="h3">Noninvasive technologies</span><span class="headingEndMark"> — </span>Several types of noninvasive commercially available technologies that measure CO and/or assess fluid responsiveness have been studied (eg, pleth variability index, pulse wave analysis [pulse wave transit time or pulse contour analysis], carbon dioxide rebreathing, and thoracic electrical bioimpedance or bioreactance devices) [<a href="#rid65">65-68</a>]. A 2017 meta-analysis concluded that the percentage error of these devices for measurements of CO can be significant compared with standard thermodilution techniques<strong><em> </em></strong>[<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H3550626918"><span class="h2">Measurement of laboratory values</span><span class="headingEndMark"> — </span>Increased serum lactate levels or lactic acidosis on sequential arterial blood gases can be an important indicator of reduced global tissue perfusion. However, these laboratory values do not provide information regarding contemporaneous clinical intravascular volume status since they are measured intermittently and do not immediately reflect acute changes. (See  <a class="medical medical_review" href="/d/html/2298.html" rel="external">"Etiology, clinical manifestations, and diagnosis of volume depletion in adults", section on 'Clinical manifestations'</a>.) </p><p class="headingAnchor" id="H1058523188"><span class="h1">CHOOSING FLUID: CRYSTALLOID, COLLOID, OR BLOOD</span></p><p class="headingAnchor" id="H4057778"><span class="h2">Crystalloid solutions</span><span class="headingEndMark"> — </span>Crystalloids are solutions of electrolytes and sterile water that may be isotonic, hypotonic, or hypertonic with respect to plasma. Balanced electrolyte solutions (also termed buffered crystalloid solutions) that have an electrolyte composition similar to plasma with the addition of a buffer (eg, lactate) are most widely used [<a href="#rid70">70</a>]. Examples include <a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">lactated Ringer</a>'s solution (also termed Hartmann's solution) or Plasmalyte. </p><p>We typically select a balanced electrolyte crystalloid solution for routine perioperative fluid administration to maintain intraoperative normovolemia. During major surgical procedures, we administer approximately 3 mL/kg per hour to replace sensible and insensible losses and support basal metabolic rate, and we administer fluid boluses (typically 250 mL) in volume responsive patients to optimize intravascular volume (see <a class="local">'Dynamic parameters to assess volume responsiveness'</a> above), and replacement of lost blood with crystalloid on a 1.5:1.0 volume basis until a blood transfusion threshold is met. We avoid dextrose-containing solutions due to the putative adverse effects of hyperglycemia [<a href="#rid71">71</a>].</p><p>We avoid administration of a large volume of normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> (NS; 0.9 percent), as this has been associated with hyperchloremic acidosis [<a href="#rid72">72-85</a>]. Risk for other adverse outcomes, particularly acute kidney injury (AKI), has been associated with NS in several observational and randomized studies [<a href="#rid73">73,74,86-89</a>]. However, results are not consistent in patients who do not receive large volumes of NS or are not critically ill [<a href="#rid72">72,81,90-92</a>]. A 2017 meta-analysis of randomized trials that included 1096 surgical patients noted that perioperative administration of buffered (ie, balanced) electrolyte solutions was associated with a lower incidence of minor metabolic derangements, particularly mild metabolic acidosis compared with NS, but did not demonstrate an effect on mortality or renal replacement therapy (RRT); however, most of these patients were not critically ill [<a href="#rid72">72</a>]. Another 2018 meta-analysis of randomized trials in more than 3700 unselected critically ill or perioperative adult patients did not find a significant reduction in mortality (odds ratio [OR] 0.90, 95% CI 0.69-1.17) or incidence of RRT (OR 1.12, 95% CI 0.80-1.58) with administration of balanced electrolyte solutions rather than NS; however, most of these patients received a low fluid volume [<a href="#rid92">92</a>]. Similarly, a 2020 single-center alternating cohort trial of infusion of large volumes of saline versus <a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">lactated Ringer</a>’s solution noted comparable outcomes including renal, respiratory, infectious, and hemorrhagic complications in 8616 patients undergoing major noncardiac surgical procedures [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H334047574"><span class="h2">Colloid solutions</span><span class="headingEndMark"> — </span>Colloids are human plasma derivatives (eg, human albumin, fresh frozen plasma [FFP]) or semisynthetic preparations (eg, hydroxyethyl starch [HES], gelatins) [<a href="#rid93">93</a>]. Colloids may be dissolved in isotonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or in a solution with a balanced electrolyte concentration similar to plasma [<a href="#rid93">93</a>].</p><p>Some clinicians prefer to use colloids in selected patients or situations in attempts to expand microvascular volume with minimal capillary leakage in fluid responsive patients, thereby minimizing the total quantity of administered fluid and edema formation [<a href="#rid94">94</a>]. For example, during blood loss, colloids may be administered on a 1:1 volume basis until a transfusion threshold is met [<a href="#rid94">94,95</a>]. Administration of 20 percent albumin results in a long-lasting plasma volume expansion lasting into the postoperative period [<a href="#rid96">96,97</a>]. In one study of patients undergoing open abdominal surgery, the intravascular half-life of 20 percent albumin was 9.1 (5.7 to 11.2) hours [<a href="#rid96">96</a>]. (See  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'</a>.) </p><p>However, evidence that colloid solutions are superior to balanced electrolyte crystalloid solutions is scant [<a href="#rid98">98-102</a>]. A study using closed loop administration of balanced HES for open abdominal surgery noted lower morbidity on postoperative day two and better disability-free survival at follow-up one year after surgery, compared with closed loop administration of balanced crystalloid solution [<a href="#rid100">100,101</a>]. A small study of administration of 20 percent albumin in the postoperative period after cardiac surgery noted less positive fluid balance and volume of fluid boluses and lower requirements for a vasopressor (<a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a>) [<a href="#rid103">103</a>]. </p><p>Overall, we minimize use of colloids since they do not provide significant hemodynamic benefits over crystalloids. When we do select a colloid to expand microvascular volume, we use albumin rather than HES.</p><p class="headingAnchor" id="H4177043207"><span class="h3">Albumin</span><span class="headingEndMark"> — </span>Human serum albumin is available in both 5 and 25 percent solutions. In some parts of the world, human serum albumin is available as 4 and 20 percent solutions. Human albumin 5 percent has a volume effect (ie, the percent of fluid administered that remains intravascular) of 70 percent, while albumin 25 percent solution is isosmotic with plasma  (<a class="graphic graphic_table graphicRef63639" href="/d/graphic/63639.html" rel="external">table 4</a>). Human albumin is pasteurized and does not transmit any known infectious diseases. (See  <a class="medical medical_review" href="/d/html/7925.html" rel="external">"Plasma derivatives and recombinant DNA-produced coagulation factors", section on 'Albumin'</a>.)</p><p>Notably, albumin is more expensive than other solutions, and may not be safer or more efficacious than synthetic colloids (eg, HES) or balanced crystalloid solutions [<a href="#rid90">90,98,104-106</a>]. (See <a class="local">'Hydroxyethyl starches'</a> below and <a class="local">'Crystalloid solutions'</a> above.) </p><p class="headingAnchor" id="H4057785"><span class="h3">Hydroxyethyl starches</span><span class="headingEndMark"> — </span>HES solutions are synthetic colloids, identified by three numbers corresponding to concentration, molecular weight, and molar substitution (ie, the average hydroxyethyl groups per one glucose unit)  (<a class="graphic graphic_table graphicRef63639" href="/d/graphic/63639.html" rel="external">table 4</a>). As an example, Hespan is HES 6 percent (600/0.75) with a volume effect of 100 percent and a high molar substitution of 0.75. Due to concerns regarding renal toxicity and effects on hemostasis, administration of HES solutions is restricted in Europe and North America [<a href="#rid90">90</a>].</p><p>A 2018 systematic review in critically ill patients with medical and surgical diagnoses noted a higher incidence of RRT in those receiving HES solutions compared with those receiving crystalloids (risk ratio [RR] 1.30, 95% CI 1.14-1.48; 8527 participants, nine studies) [<a href="#rid98">98</a>]. Also, a 2010 systematic review in mixed surgical and nonsurgical patient populations found an overall increased risk of author-defined kidney failure in surgical and medical patients receiving HES solutions (including some who received highly substituted HES products) compared with those receiving various other types of fluid therapy [<a href="#rid107">107</a>]. Furthermore, administration of HES solutions in cardiac surgical patients increased risk of postoperative bleeding and transfusion compared with albumin [<a href="#rid108">108</a>]. </p><p>However, data are not consistent. A 2022 meta-analysis of randomized trials (seven trials; 2398 patients) noted that intraoperative intravascular volume replacement with 6 percent <a class="drug drug_general" data-topicid="8522" href="/d/drug information/8522.html" rel="external">hetastarch</a> 130/.04 during open abdominal surgery was not associated with increased risk of AKI after 30 postoperative days compared with using crystalloid solutions (eg, lactated Ringers, Plasmalyte, NS) [<a href="#rid109">109</a>]. Furthermore, randomized trials comparing outcomes after administration of 6 percent hetastarch 130/.04 versus 5 percent albumin noted similar risk for AKI and other serious postoperative complications with either colloid [<a href="#rid106">106,110</a>]. Notably, risk of HES-induced renal toxicity and other complications is likely influenced by the molar substitution level in the specific product, with less risk for more recently developed low substituted HES products such as 6 percent hetastarch 130/.04 [<a href="#rid111">111</a>]. Nevertheless, in 2021, the FDA required additional warnings about the risk of death, bleeding, and AKI [<a href="#rid112">112</a>].</p><p>Since HES products impair platelet reactivity and decrease circulating plasma concentrations of coagulation factor VIII and von Willebrand factor, administration may result in weakening of clot formation and more transfusions of blood products including FFP, cryoprecipitate, and platelets compared with other fluid choices [<a href="#rid98">98,113-115</a>]. A 2018 systematic review of randomized trials in critically ill patients noted a higher incidence of transfusion in those receiving starch solutions compared with those receiving crystalloids (RR 1.19, 95% CI 1.02-1.39; 1917 participants, eight studies) [<a href="#rid98">98</a>]. HES products with low molar substitution (eg, <a class="drug drug_general" data-topicid="10203" href="/d/drug information/10203.html" rel="external">pentastarch</a> and <a class="drug drug_general" data-topicid="8728" href="/d/drug information/8728.html" rel="external">tetrastarch</a>) may have less effect on hemostasis [<a href="#rid116">116</a>]. One 2008 meta-analysis of randomized trials compared HES solutions with low (0.4) versus a somewhat higher (0.5) molar substitution, noting significantly less blood loss (404 mL) and red blood cell (RBC) transfusion (137 mL) in patients receiving the low substituted product (seven trials; 449 patients) [<a href="#rid117">117</a>]. Subsequently, a 2020 randomized trial noted similar coagulation, platelet count, and platelet function parameters with use of 6 percent <a class="drug drug_general" data-topicid="8522" href="/d/drug information/8522.html" rel="external">hetastarch</a> 130/.04 for plasma volume replacement compared with 5 percent albumin [<a href="#rid118">118</a>]. Furthermore, a multicenter retrospective study noted that bleeding rates did not change after switching from HES solution to albumin for musculoskeletal surgical procedures (3078 total patients) [<a href="#rid119">119</a>].</p><p class="headingAnchor" id="H4057828"><span class="h3">Gelatins</span><span class="headingEndMark"> — </span>Gelatins are not used in the United States because of their short duration of action (two to three hours) due to rapid excretion in the urine, possible effects on coagulation, and a relatively high incidence of anaphylaxis [<a href="#rid90">90,93,120</a>]. (See  <a class="medical medical_review" href="/d/html/2077.html" rel="external">"Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Colloids and plasma expanders'</a>.)</p><p>Gelatins are used in some countries because they are inexpensive and have a volume effect of 70 to 80 percent  (<a class="graphic graphic_table graphicRef63639" href="/d/graphic/63639.html" rel="external">table 4</a>) [<a href="#rid121">121</a>]. </p><p class="headingAnchor" id="H437726373"><span class="h2">Blood transfusion</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Red blood cells</strong> – RBCs are used to replace intraoperative blood loss when a transfusion threshold is met, as discussed separately. (See  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Plasma</strong> – Decisions regarding transfusion of plasma derivatives of human blood (eg, fresh frozen plasma [FFP], cryoprecipitate) are based on estimates of the amount of current and expected ongoing blood loss and evidence of intractable microvascular bleeding indicating abnormal hemostasis, ideally with confirmation by diagnostic test results. In patients with disseminated intravascular coagulation, administration of colloid lacking coagulation factors may exacerbate depletion of natural anticoagulants needed to prevent microthrombosis; thus, plasma rather than albumin is typically preferred for volume replacement in these patients [<a href="#rid122">122</a>]. Further discussions regarding transfusion are available in a separate topic. (See  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Plasma'</a> and  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Cryoprecipitate or fibrinogen concentrate'</a>.)</p><p></p><p class="headingAnchor" id="H254311346"><span class="h1">CHOOSING A FLUID MANAGEMENT STRATEGY</span><span class="headingEndMark"> — </span>Our intraoperative fluid management strategy and selection of noninvasive or invasive monitoring is based on the expected blood loss and the likelihood of nonhemorrhagic fluid shifts (eg, from open body cavities and wounds) during the planned surgical procedure (see <a class="local">'Monitoring intravascular volume status'</a> above). Other factors influencing these decisions include patient comorbidities (eg, anemia, congestive heart failure [CHF], chronic obstructive pulmonary disease [COPD]) and planned postoperative disposition (eg, home, hospital ward, intensive care unit).</p><p class="headingAnchor" id="H2312279859"><span class="h2">Minimally/moderately invasive surgery</span><span class="headingEndMark"> — </span>For most relatively brief minimally or moderately invasive surgery with planned early postoperative ambulation, we administer 1 to 2 L of a balanced electrolyte solution for procedures that will not incur significant fluid shifts or blood loss. This volume of fluid is typically administered during surgery over a period of 30 minutes to two hours. Such empiric but limited fluid administration for less invasive surgery in ambulatory patients addresses the mild dehydration caused by preoperative fasting and is associated with less risk for postoperative nausea and vomiting (PONV) or pain compared with controls receiving minimal fluids [<a href="#rid123">123,124</a>]. In patients with a history of CHF or COPD, fluid is administered cautiously (eg, in increments), with a total volume in the lower end of this range.</p><p class="headingAnchor" id="H3439693921"><span class="h2">Major invasive surgery</span><span class="headingEndMark"> — </span>For adult patients undergoing major invasive surgical procedures, we select one of the following strategies:</p><p class="headingAnchor" id="H2410959413"><span class="h3">Restrictive (zero-balance) strategy</span><span class="headingEndMark"> — </span>For invasive major surgery with expected blood loss &lt;500 mL, we typically employ a restrictive zero-balance approach that minimizes fluid administration, particularly if no invasive monitoring of dynamic hemodynamic parameters is planned (eg, intra-arterial catheter, transesophageal echocardiography [TEE] or esophageal Doppler probe). With this approach, only the fluid that is lost during surgery is replaced, including the following strategies [<a href="#rid12">12</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>During the intraoperative period, patients receive a balanced electrolyte crystalloid solution administered at a rate of approximately 3 mL/kg per hour to replace sensible and insensible losses and support metabolic rate [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For blood loss, additional fluid may be administered. Studies suggest that the optimal crystalloid-to-blood volume ratio is approximately 1.5:1.0, and that the optimal colloid-to-blood ratio is 1:1, until a threshold for red blood cell (RBC) transfusion is reached [<a href="#rid125">125-128</a>]. (See <a class="local">'Crystalloid solutions'</a> above and <a class="local">'Colloid solutions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We avoid "preloading" of crystalloids prior to a neuraxial block or induction of general anesthesia. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We avoid replacement of nonanatomic "third space" losses since evidence suggests that this practice has no benefit and may cause morbidity [<a href="#rid9">9,129,130</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We avoid extremely deep anesthesia (eg, bispectral index values &lt;40) that may result in hypotension treated with unnecessary additional fluid. If necessary, vasopressor agents such as <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a> may be employed to treat hypotension caused by administration of anesthetic agents and/or neuraxial block [<a href="#rid131">131,132</a>]. (See  <a class="medical medical_review" href="/d/html/400.html" rel="external">"Accidental awareness during general anesthesia", section on 'Brain monitoring'</a> and  <a class="medical medical_review" href="/d/html/94532.html" rel="external">"Hemodynamic management during anesthesia in adults", section on 'Hypotension: Prevention and treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Administration of a total volume of balanced electrolyte solutions that modestly exceeds zero fluid balance is appropriate in patients with evidence of hypovolemia [<a href="#rid133">133</a>].</p><p></p><p>A potential disadvantage of this approach is that hypovolemia may not be clinically appreciated. Also, if hypotension occurs, it may be difficult to determine the etiology (eg, surgical volume losses or other causes such as cardiovascular responses to anesthetic agents). However, in most studies, restrictive fluid therapy has been associated with better outcomes than traditional liberal or fixed-volume approaches for major elective surgical procedures [<a href="#rid11">11,12,22,90,134-136</a>].</p><p>A modified approach was described in a 2014 randomized trial in 166 patients undergoing radical cystectomy employing a restrictive approach (1 mL/kg/hour) combined with low-dose <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> infusion during the initial portion of the surgery, subsequently followed by hydration (3 mL/kg/hour) during the last part of the surgical procedure [<a href="#rid137">137</a>]. This so-called "restrictive deferred hydration" approach was associated with fewer complications (RR 0.70, 95% CI 0.55-0.88) and a lower median duration of hospital stay (15 days, range 11 to 27) than a liberal approach with 6 mL/kg/hour (17 days, range 11 to 95). </p><p>Notably, variability in study design has resulted in inconsistent results. A randomized trial in 3000 patients undergoing major abdominal surgery noted that a restrictive (zero-balance) fluid regimen was associated with a higher rate of acute kidney injury (AKI) compared with a liberal fluid regimen (8.6 versus 5 percent; RR 1.71, 95% CI 1.29-2.27) [<a href="#rid34">34</a>]. A limitation of this study was its pragmatic design in that perioperative care was not standardized and there was a wide variation in the anesthetic and analgesic techniques, including the use of epidural analgesia, variable intraoperative hemodynamic management, and variable postoperative care. The total fluid volume administered (balanced electrolyte solutions in both groups) during and up to 24 hours after surgery was 3.7 versus 6.1 L in the restrictive and liberal groups, respectively. These volumes were lower than traditional liberal fluid strategy totals [<a href="#rid133">133</a>]. A retrospective observational study also noted an association between use of a restrictive strategy with AKI in patients undergoing cystectomy (odds ratio [OR] 0.79, 95% CI 0.68-0.91) [<a href="#rid138">138</a>]. </p><p>Taken together, these studies suggest that hypovolemia should be recognized and appropriately treated with fluid to avoid hemodynamic compromise and organ ischemia (see <a class="local">'Goal-directed fluid therapy'</a> below). However, excessive perioperative fluid administration should also be avoided since this can cause tissue and organ edema [<a href="#rid3">3,133,139</a>]. (See <a class="local">'Avoid traditional liberal or fixed-volume approaches'</a> below.)</p><p class="headingAnchor" id="H626508222"><span class="h3">Goal-directed fluid therapy</span><span class="headingEndMark"> — </span>For invasive major surgery with anticipated significant blood losses (eg, &gt;500 mL) and/or fluid shifts, we typically employ a goal-directed approach to fluid administration using one or more invasive dynamic hemodynamic parameters to achieve a prespecified goal (see <a class="local">'Dynamic parameters to assess volume responsiveness'</a> above) [<a href="#rid1">1</a>]. With this approach, we ensure that intravascular volume status is optimal before adding vasopressor therapy to achieve optimal blood pressure [<a href="#rid8">8</a>]. Clinical questions regarding goal-directed therapy (GDT) that remain unanswered include which types of patients are most likely to benefit, optimal timing of the use of GDT (preoperative, intraoperative, and/or postoperative), which outcome measures or endpoints are optimal, which combinations of therapies constitute the best approach (eg, fluids with or without vasopressors or inotropic agents), and how long the regimen should be maintained during the postoperative period.</p><p class="headingAnchor" id="H2007089508"><span class="h4">Specific techniques</span></p><p class="bulletIndent1"><span class="glyph">●</span>As with a restrictive strategy, patients receive balanced electrolyte crystalloid solution administered at a rate of approximately 3 mL/kg per hour during the intraoperative period to replace sensible and insensible losses and support metabolic rate [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A disadvantage of GDT is that it requires invasive monitoring of dynamic hemodynamic parameters [<a href="#rid8">8,12,59,140</a>]. We consider the following factors in selection of monitoring modalities:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In most patients undergoing major surgery, we use the intra-arterial waveform tracing for automated measurements of pulse pressure variations (PPV) or stroke volume variation (SVV), or visually estimated or manually calculated PPV or systolic pressure variations (SPV), in order to determine responses to fluid boluses (typically 250 mL increments) [<a href="#rid141">141</a>]. For some patients, fluid boluses are administered in 100 mL increments to avoid excessive fluid administration and consequent hypervolemia  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef85848" href="/d/graphic/85848.html" rel="external">figure 2</a>) [<a href="#rid142">142</a>]. (See <a class="local">'Hypervolemia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For high-risk patients undergoing a surgical procedure with expected blood loss &gt;1000 mL, significant nonhemorrhagic fluid losses, and/or likely prolonged duration, we typically use a commercially available device that provides automated calculation of PPV, SVV, or SPV by analyzing the intra-arterial waveform tracing to assess responses to fluid challenges. An alternative is use of an esophageal Doppler device to estimate stroke volume (SV) [<a href="#rid65">65</a>]. TEE is another option, allowing visual qualitative evaluation or quantitative measurements of the left ventricular (LV) cavity size to monitor fluid responsiveness  (<a class="graphic graphic_movie graphicRef104149" href="/d/graphic/104149.html" rel="external">movie 1</a> and <a class="graphic graphic_diagnosticimage graphicRef109236" href="/d/graphic/109236.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef104503" href="/d/graphic/104503.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef106967" href="/d/graphic/106967.html" rel="external">table 3</a>). (See <a class="local">'Dynamic parameters to assess volume responsiveness'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For a GDT approach, fluid is administered to achieve a prespecified goal: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If respiratory variations in the arterial pressure waveform (PPV or SPV) are &gt;10 to 15 percent, then the patient is assumed to be fluid responsive and we administer fluid boluses of a balanced electrolyte crystalloid solution (typically in 250 mL increments) [<a href="#rid24">24,50,142</a>]. Once change in the monitored dynamic parameter is &lt;10 percent, fluid administration is stopped to avoid hypervolemia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If SV estimates are used for dynamic hemodynamic monitoring, the typical goal of therapy is to achieve and maintain optimal intravascular volume with maximum SV. The new SV value after fluid administration has resulted in &lt;10 percent change is recorded as the new baseline goal value (representing the maximum SV to be maintained). (See <a class="local">'Respiratory variations in arterial pressure waveform'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If TEE is employed, hypovolemic and hypervolemic states can be quickly assessed by visual qualitative evaluation or quantitative measurements of LV cavity size. Fluid administration is stopped once normovolemia has been achieved  (<a class="graphic graphic_movie graphicRef104149" href="/d/graphic/104149.html" rel="external">movie 1</a> and <a class="graphic graphic_diagnosticimage graphicRef109236" href="/d/graphic/109236.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef104503" href="/d/graphic/104503.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef106967" href="/d/graphic/106967.html" rel="external">table 3</a>). (See <a class="local">'Echocardiography'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although most studies evaluating GDT have used boluses of colloid fluid [<a href="#rid143">143,144</a>], we typically select a balanced crystalloid solution for fluid boluses. Randomized trials in patients undergoing elective abdominal surgery have found little difference in postoperative complications or any clinical benefit with use of a 6 percent hydroxyethyl starch (HES) colloid solution for fluid boluses compared with a balanced crystalloid solution to provide GDT [<a href="#rid101">101,125</a>]. (See <a class="local">'Choosing fluid: Crystalloid, colloid, or blood'</a> above.)</p><p></p><p class="headingAnchor" id="H796495526"><span class="h4">Comparison with other strategies</span><span class="headingEndMark"> — </span>Variable benefits have been noted in comparisons of GDT with other fluid management strategies. Numerous limitations in study design may account for variable benefits of GDT compared with other fluid management strategies. These include clinical heterogeneity among trials with differing definitions for GDT, lack of well-defined endpoints, different types of fluid therapy, different devices used to monitor dynamic hemodynamic parameters, variations in management of the control group, different types of surgery, and small sample sizes [<a href="#rid145">145-149</a>]. In addition, most studies have included only limited information regarding anesthetic techniques and perioperative surgical care [<a href="#rid146">146</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison with traditional liberal fluid strategies</strong> – GDT appears to be superior to traditional fixed-volume or liberal fluid approaches (see <a class="local">'Avoid traditional liberal or fixed-volume approaches'</a> below). A 2022 meta-analysis of randomized trials in noncardiac surgical patients noted a trend toward reduced mortality with GDT (OR 0.84, 95% CI 0.64-1.09) and shorter length of hospital stay (mean difference -0.72 days, 95% CI -1.10 to -0.25 days), with low certainty evidence for these primary outcomes compared with standard of care (76 trials; 9081 patients) [<a href="#rid150">150</a>]. In subgroup analyses, GDT was also favored for other outcomes (pneumonia, acute respiratory distress syndrome, surgical site infection, anastomotic leakage, and delirium) compared with standard of care, but with low or moderate certainty of evidence. A 2018 meta-analysis noted similar results with GDT compared with standard care (eg, lower risk of respiratory, renal, wound, and gastrointestinal complications, with shorter time to hospital discharge) [<a href="#rid145">145</a>].</p><p></p><p class="bulletIndent1">However, data are not consistent [<a href="#rid151">151-157</a>]. In particular, GDT does not appear to offer additional benefits over a restrictive fluid approach for patients managed with protocols to achieve enhanced recovery after surgery (ERAS) [<a href="#rid151">151,154-157</a>]. The likely reason is that ERAS protocols implement multiple processes that each reduce the risk of perioperative fluid imbalances (eg, avoidance of preoperative dehydration, use of an intraoperative restrictive fluid approach, emphasis on early postoperative alimentation and ambulation). One meta-analysis assessing GDT in this setting found no benefit (or harm) with its use [<a href="#rid151">151</a>]. (See  <a class="medical medical_review" href="/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Fluid management'</a>.)</p><p></p><p class="bulletIndent1">In some studies, administration of optimal fluid volume using a GDT approach was combined with attempts to achieve optimal hemodynamic management, thereby ensuring optimal tissue and organ perfusion in individual patients [<a href="#rid149">149,158</a>]. A 2018 meta-analysis of GDT (defined as fluid and/or vasopressor therapy titrated to hemodynamic goals (eg, cardiac output [CO]) was associated with lower risk of mortality (OR 0.66, 95% CI 0.50-0.87), pneumonia (OR 0.69, 95% CI 0.51-0.92), AKI (OR 0.73, 95% CI 0.58-0.92), wound infection (OR 0.48, 95% CI 0.37-0.63), and shorter length of hospital stay (-0.9 days; 95% CI -1.3 to -0.5 days), compared with fluid management at the discretion of treating clinicians (11,659 patients; 95 randomized trials) [<a href="#rid145">145</a>]. Another 2018 meta-analysis noted that studies using dynamic hemodynamic parameters to optimize intravascular volume and achieve optimal cardiac output (CO) or index (CI) reported less short-term mortality (OR 0.45, 95% CI 0.24-0.85) and less overall morbidity (OR 0.41, 95% CI 0.28-0.58), compared with standard fluid therapy (13 trials; 1100 total patients) [<a href="#rid159">159</a>]. Notably, data from other trials in this meta-analysis that employed GDT without attempts to optimize CO or CI that were analyzed separately did not note differences between GDT versus standard fluid management strategies (six trials; 524 patients) [<a href="#rid159">159</a>]. Similarly, a 2020 network meta-analysis noted that studies employing GDT aimed at optimizing intravascular volume as well as stroke volume and CO most effectively reduced the incidence of surgical site infections and other postoperative complications compared with usual care (43 trials; 8100 patients). One 2021 randomized trial employed computer-assisted individualized hemodynamic management that included a fluid management support system for GDT combined with a closed-loop system to titrate <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> [<a href="#rid160">160</a>]. The investigators reported higher mean CI at the end of the procedure as well as lower total requirements for norepinephrine and lower fluid balances in patients receiving computer-assisted management, compared with those receiving manually directed GDT and manually titrated norepinephrine.  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison with restrictive fluid strategies</strong> – Whether GDT is superior to a restrictive fluid strategy is less certain as there are limited data comparing GDT to this approach. In a 2019 meta-analysis of randomized trials in patients undergoing major noncardiac surgery, very low-certainty evidence suggested that restrictive fluid therapy does not affect the risk of complications (RR 1.61, 95% CI 0.78-3.34; five studies; 484 participants), but may increase the risk of all-cause mortality (risk difference [RD] 0.03, 95% CI 0.00-0.06) [<a href="#rid144">144</a>].</p><p></p><p class="headingAnchor" id="H3041008465"><span class="h2">Avoid traditional liberal or fixed-volume approaches</span><span class="headingEndMark"> — </span>Traditional liberal or fixed-volume approaches have been abandoned. Evidence suggests that these approaches resulted in administration of a large volume of crystalloid solution with likely fluid overload. Specifically, traditional fixed-volume approaches were based upon:</p><p class="bulletIndent1"><span class="glyph">●</span>Predetermined calculations that included administration of fluid to account for presumed preoperative deficits, as well as intraoperative blood and urinary losses.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional fluid administered to compensate for calculated non-anatomic "third space" fluid losses during the surgical procedure. This practice is inappropriate, as it has been well-established that such third space losses do not exist [<a href="#rid9">9,129,130</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Large volumes of fluid as preloading before a neuraxial block. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Replacement of initial blood loss with crystalloid volume that was three times the amount of lost blood. For example, if blood loss was estimated to be 500 to 1000 mL, then 1500 to 3000 mL of crystalloid was typically administered. This calculation is not supported by available data. Rather, optimal volume ratios to compensate for lost blood are estimated to be 1.5:1.0 for crystalloid and 1:1 for colloid, as discussed above [<a href="#rid125">125-127</a>]. (See <a class="local">'Crystalloid solutions'</a> above and <a class="local">'Colloid solutions'</a> above.)</p><p></p><p>These traditional fixed volume calculations for fluid administration resulted in a higher incidence of perioperative tissue and organ edema, and were associated with increased risk for adverse outcomes compared with restrictive or goal-directed approaches [<a href="#rid3">3,11,12,16,22,59,140,161-166</a>]. </p><p class="headingAnchor" id="H1058523279"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes and consequences of intravascular volume derangements</strong> – Normovolemia/euvolemia should be maintained throughout the perioperative period to maintain adequate tissue perfusion. Both hypovolemia and hypervolemia are associated with postoperative morbidity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypovolemia</strong> – Hypovolemia is common due to preoperative, anesthesia-related, and surgery-related factors. Hypovolemia results in reduced cardiac output and tissue perfusion. Persistent hypovolemia can lead to shock and multiorgan failure. (See <a class="local">'Hypovolemia'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypervolemia</strong> – Development of hypervolemia is generally due to excessive volume administration (eg, to treat hemodynamic instability). Hypervolemia can result in reduced tissue perfusion due to tissue edema and clinically significant postoperative fluid retention. (See <a class="local">'Hypervolemia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring intravascular volume status</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Traditional static parameters</strong> – Static physiological parameters such as blood pressure, heart rate, central venous pressure, and urine output are monitored during surgery to provide supplemental data regarding intravascular volume status. However, significant reduction in tissue perfusion may not be recognized. (See <a class="local">'Traditional static parameters'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dynamic hemodynamic parameters</strong> – Dynamic hemodynamic indices are used to assess responses to a fluid challenge (ie, volume responsiveness) and guide goal-directed fluid therapy in patients undergoing major invasive surgical procedures, particularly if large blood losses or fluid shifts are anticipated. These include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory variation using the intra-arterial waveform tracing for estimates or calculations of pulse pressure variations (PPV), stroke volume variation (SVV), systolic pressure variations (SPV)  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef85848" href="/d/graphic/85848.html" rel="external">figure 2</a> and <a class="graphic graphic_table graphicRef85850" href="/d/graphic/85850.html" rel="external">table 2</a>), or stroke volume (SV). (See <a class="local">'Respiratory variations in arterial pressure waveform'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ultrasound technologies including esophageal Doppler measurements of blood flow velocity in the descending thoracic aorta to estimate SV, or transesophageal echocardiography (TEE) or transthoracic echocardiography (TTE) for visual qualitative assessment or measurements of left ventricular cavity size  (<a class="graphic graphic_movie graphicRef104149" href="/d/graphic/104149.html" rel="external">movie 1</a> and <a class="graphic graphic_diagnosticimage graphicRef109236" href="/d/graphic/109236.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef104503" href="/d/graphic/104503.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef106967" href="/d/graphic/106967.html" rel="external">table 3</a>). (See <a class="local">'Esophageal doppler technology'</a> above and <a class="local">'Echocardiography'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory measurements</strong> – Increased serum lactate levels or lactic acidosis indicate reduced global tissue perfusion, but are measured intermittently and do not reflect acute changes. (See <a class="local">'Measurement of laboratory values'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of fluid</strong>  (<a class="graphic graphic_table graphicRef63639" href="/d/graphic/63639.html" rel="external">table 4</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Balanced crystalloid solutions </strong>– We suggest a balanced electrolyte solution (eg, Ringer's lactate, Plasmalyte) rather than normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or colloid to maintain intraoperative normovolemia (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), including replacement of sensible and insensible losses, fluid boluses (typically 250 mL) in volume responsive patients, and replacement of lost blood on a 1.5:1.0 volume basis until a transfusion threshold is met. (See <a class="local">'Crystalloid solutions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Colloid solutions</strong> – During blood loss, some clinicians prefer to administer colloid (eg, albumin) on a 1:1 volume basis until a transfusion threshold is met. We minimize colloid use due to insignificant hemodynamic benefits compared with crystalloids. We administer albumin rather than hydroxyethyl starch (HES) when a colloid is selected. (See <a class="local">'Colloid solutions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Blood transfusion </strong>– Red blood cells (RBCs) are used to replace blood loss when a transfusion threshold is met. Decisions regarding transfusion of plasma derivatives (eg, fresh frozen plasma [FFP]) are based on estimates of blood loss and evidence of abnormal hemostasis. (See <a class="local">'Blood transfusion'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of a fluid management strategy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Minimally or moderately invasive procedures </strong>– For most adult patients undergoing minimally or moderately invasive surgical procedures, we administer 1 to 2 L of a balanced electrolyte solution to provide adequate intravascular hydration. (See <a class="local">'Minimally/moderately invasive surgery'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Major invasive procedures </strong>– For major invasive surgical procedures, we suggest a restrictive (zero-balance) or a goal-directed therapy (GDT) approach to fluid administration (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). (See <a class="local">'Major invasive surgery'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Restrictive strategy </strong>– For procedures without significant anticipated blood loss (eg, &lt;500 mL) and/or other fluid shifts, we use a restrictive approach replacing only fluid lost during the procedure (approximately 3 mL/kg per hour to replace sensible and insensible losses). (See <a class="local">'Restrictive (zero-balance) strategy'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Goal-directed fluid therapy </strong>– For procedures with significant anticipated blood losses (eg, &gt;500 mL) and/or fluid shifts, we use GDT with invasive dynamic hemodynamic parameters to achieve a pre-specified goal. (See <a class="local">'Goal-directed fluid therapy'</a> above and <a class="local">'Dynamic parameters to assess volume responsiveness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Avoid liberal fixed-volume strategies </strong>– We avoid traditional liberal or fixed-volume approaches that lead to administration of large volumes of crystalloid solution, tissue edema, and associated adverse outcomes. (See <a class="local">'Avoid traditional liberal or fixed-volume approaches'</a> above.) </p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Thacker JK, Mountford WK, Ernst FR, et al. Perioperative Fluid Utilization Variability and Association With Outcomes: Considerations for Enhanced Recovery Efforts in Sample US Surgical Populations. Ann Surg 2016; 263:502.</a></li><li><a class="nounderline abstract_t">Bellamy MC. Wet, dry or something else? Br J Anaesth 2006; 97:755.</a></li><li><a class="nounderline abstract_t">Shin CH, Long DR, McLean D, et al. Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Ann Surg 2018; 267:1084.</a></li><li><a class="nounderline abstract_t">Zarbock A, Koyner JL, Hoste EAJ, Kellum JA. Update on Perioperative Acute Kidney Injury. Anesth Analg 2018; 127:1236.</a></li><li><a class="nounderline abstract_t">Myrberg T, Lindelöf L, Hultin M. Effect of preoperative fluid therapy on hemodynamic stability during anesthesia induction, a randomized study. Acta Anaesthesiol Scand 2019; 63:1129.</a></li><li><a class="nounderline abstract_t">Jacob M, Chappell D, Conzen P, et al. Blood volume is normal after pre-operative overnight fasting. Acta Anaesthesiol Scand 2008; 52:522.</a></li><li><a class="nounderline abstract_t">Danielsson EJD, Lejbman I, Åkeson J. Fluid deficits during prolonged overnight fasting in young healthy adults. Acta Anaesthesiol Scand 2019; 63:195.</a></li><li><a class="nounderline abstract_t">Miller TE, Myles PS. Perioperative Fluid Therapy for Major Surgery. Anesthesiology 2019; 130:825.</a></li><li><a class="nounderline abstract_t">Jacob M, Chappell D, Rehm M. The 'third space'--fact or fiction? Best Pract Res Clin Anaesthesiol 2009; 23:145.</a></li><li><a class="nounderline abstract_t">Lamke LO, Nilsson GE, Reithner HL. Water loss by evaporation from the abdominal cavity during surgery. Acta Chir Scand 1977; 143:279.</a></li><li><a class="nounderline abstract_t">Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723.</a></li><li><a class="nounderline abstract_t">Brandstrup B. Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 2006; 20:265.</a></li><li><a class="nounderline abstract_t">Brauer KI, Svensén C, Hahn RG, et al. Volume kinetic analysis of the distribution of 0.9% saline in conscious versus isoflurane-anesthetized sheep. Anesthesiology 2002; 96:442.</a></li><li><a class="nounderline abstract_t">Connolly CM, Kramer GC, Hahn RG, et al. Isoflurane but not mechanical ventilation promotes extravascular fluid accumulation during crystalloid volume loading. Anesthesiology 2003; 98:670.</a></li><li><a class="nounderline abstract_t">Lowell JA, Schifferdecker C, Driscoll DF, et al. Postoperative fluid overload: not a benign problem. Crit Care Med 1990; 18:728.</a></li><li><a class="nounderline abstract_t">Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002; 89:622.</a></li><li><a class="nounderline abstract_t">Arieff AI. Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest 1999; 115:1371.</a></li><li><a class="nounderline abstract_t">Nisanevich V, Felsenstein I, Almogy G, et al. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005; 103:25.</a></li><li><a class="nounderline abstract_t">Mayberry JC, Welker KJ, Goldman RK, Mullins RJ. Mechanism of acute ascites formation after trauma resuscitation. Arch Surg 2003; 138:773.</a></li><li><a class="nounderline abstract_t">Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003; 138:637.</a></li><li><a class="nounderline abstract_t">Bentzer P, Griesdale DE, Boyd J, et al. Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? JAMA 2016; 316:1298.</a></li><li><a class="nounderline abstract_t">Joshi GP. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 2005; 101:601.</a></li><li><a class="nounderline abstract_t">Kouz K, Bergholz A, Timmermann LM, et al. The Relation Between Mean Arterial Pressure and Cardiac Index in Major Abdominal Surgery Patients: A Prospective Observational Cohort Study. Anesth Analg 2022; 134:322.</a></li><li><a class="nounderline abstract_t">Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 2009; 37:2642.</a></li><li><a class="nounderline abstract_t">Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172.</a></li><li><a class="nounderline abstract_t">Magder S. Fluid status and fluid responsiveness. Curr Opin Crit Care 2010; 16:289.</a></li><li><a class="nounderline abstract_t">Cecconi M, Aya HD. Central venous pressure cannot predict fluid-responsiveness. Evid Based Med 2014; 19:63.</a></li><li><a class="nounderline abstract_t">Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology 2008; 108:735.</a></li><li><a class="nounderline abstract_t">Eskesen TG, Wetterslev M, Perner A. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med 2016; 42:324.</a></li><li><a class="nounderline abstract_t">Mark JB. Central venous pressure monitoring: clinical insights beyond the numbers. J Cardiothorac Vasc Anesth 1991; 5:163.</a></li><li><a class="nounderline abstract_t">Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 2013; 41:1774.</a></li><li><a class="nounderline abstract_t">Egal M, Erler NS, de Geus HR, et al. Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis. Anesth Analg 2016; 122:173.</a></li><li><a class="nounderline abstract_t">Mizota T, Yamamoto Y, Hamada M, et al. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 2017; 119:1127.</a></li><li><a class="nounderline abstract_t">Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med 2018; 378:2263.</a></li><li><a class="nounderline abstract_t">Myles PS, McIlroy DR, Bellomo R, Wallace S. Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br J Anaesth 2019; 122:726.</a></li><li><a class="nounderline abstract_t">Kunst G, Ostermann M. Intraoperative permissive oliguria - how much is too much? Br J Anaesth 2017; 119:1075.</a></li><li><a class="nounderline abstract_t">Md Ralib A, Pickering JW, Shaw GM, Endre ZH. The urine output definition of acute kidney injury is too liberal. Crit Care 2013; 17:R112.</a></li><li><a class="nounderline abstract_t">Renner J, Scholz J, Bein B. Monitoring fluid therapy. Best Pract Res Clin Anaesthesiol 2009; 23:159.</a></li><li><a class="nounderline abstract_t">Knotzer H, Hasibeder WR. Microcirculatory function monitoring at the bedside--a view from the intensive care. Physiol Meas 2007; 28:R65.</a></li><li><a class="nounderline abstract_t">Funk DJ, Moretti EW, Gan TJ. Minimally invasive cardiac output monitoring in the perioperative setting. Anesth Analg 2009; 108:887.</a></li><li><a class="nounderline abstract_t">Desebbe O, Cannesson M. Using ventilation-induced plethysmographic variations to optimize patient fluid status. Curr Opin Anaesthesiol 2008; 21:772.</a></li><li><a class="nounderline abstract_t">Cecconi M, Parsons AK, Rhodes A. What is a fluid challenge? Curr Opin Crit Care 2011; 17:290.</a></li><li><a class="nounderline abstract_t">Ansari BM, Zochios V, Falter F, Klein AA. Physiological controversies and methods used to determine fluid responsiveness: a qualitative systematic review. Anaesthesia 2016; 71:94.</a></li><li><a class="nounderline abstract_t">Thiele RH, Bartels K, Gan TJ. Inter-device differences in monitoring for goal-directed fluid therapy. Can J Anaesth 2015; 62:169.</a></li><li><a class="nounderline abstract_t">Perel A. Using Dynamic Variables to Guide Perioperative Fluid Management. Anesthesiology 2020; 133:929.</a></li><li><a class="nounderline abstract_t">Thiele RH, Colquhoun DA, Blum FE, Durieux ME. The ability of anesthesia providers to visually estimate systolic pressure variability using the "eyeball" technique. Anesth Analg 2012; 115:176.</a></li><li><a class="nounderline abstract_t">Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care 2016; 6:111.</a></li><li><a class="nounderline abstract_t">Jozwiak M, Monnet X, Teboul JL. Pressure Waveform Analysis. Anesth Analg 2018; 126:1930.</a></li><li><a class="nounderline abstract_t">Si X, Xu H, Liu Z, et al. Does Respiratory Variation in Inferior Vena Cava Diameter Predict Fluid Responsiveness in Mechanically Ventilated Patients? A Systematic Review and Meta-analysis. Anesth Analg 2018; 127:1157.</a></li><li><a class="nounderline abstract_t">Cannesson M, Le Manach Y, Hofer CK, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology 2011; 115:231.</a></li><li><a class="nounderline abstract_t">Yang SY, Shim JK, Song Y, et al. Validation of pulse pressure variation and corrected flow time as predictors of fluid responsiveness in patients in the prone position. Br J Anaesth 2013; 110:713.</a></li><li><a class="nounderline abstract_t">Biais M, Bernard O, Ha JC, et al. Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery. Br J Anaesth 2010; 104:407.</a></li><li><a class="nounderline abstract_t">Messina A, Pelaia C, Bruni A, et al. Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. Anesth Analg 2018; 127:1353.</a></li><li><a class="nounderline abstract_t">Michard F, Biais M. Rational fluid management: dissecting facts from fiction. Br J Anaesth 2012; 108:369.</a></li><li><a class="nounderline abstract_t">Jeong DM, Ahn HJ, Park HW, et al. Stroke Volume Variation and Pulse Pressure Variation Are Not Useful for Predicting Fluid Responsiveness in Thoracic Surgery. Anesth Analg 2017; 125:1158.</a></li><li><a class="nounderline abstract_t">Raphael J, Regali LA, Thiele RH. Hemodynamic monitoring in thoracic surgical patients. Curr Opin Anaesthesiol 2017; 30:7.</a></li><li><a class="nounderline abstract_t">Lansdorp B, Lemson J, van Putten MJ, et al. Dynamic indices do not predict volume responsiveness in routine clinical practice. Br J Anaesth 2012; 108:395.</a></li><li><a class="nounderline abstract_t">Kimura A, Suehiro K, Juri T, et al. Hemodynamic Changes via the Lung Recruitment Maneuver Can Predict Fluid Responsiveness in Stroke Volume and Arterial Pressure During One-Lung Ventilation. Anesth Analg 2021; 133:44.</a></li><li><a class="nounderline abstract_t">Abbas SM, Hill AG. Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008; 63:44.</a></li><li><a class="nounderline abstract_t">Bisgaard J, Gilsaa T, Rønholm E, Toft P. Optimising stroke volume and oxygen delivery in abdominal aortic surgery: a randomised controlled trial. Acta Anaesthesiol Scand 2013; 57:178.</a></li><li><a class="nounderline abstract_t">Porter TR, Shillcutt SK, Adams MS, et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2015; 28:40.</a></li><li><a class="nounderline abstract_t">Reeves ST, Finley AC, Skubas NJ, et al. Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 2013; 117:543.</a></li><li><a class="nounderline abstract_t">Ramsingh D, Bronshteyn YS, Haskins S, Zimmerman J. Perioperative Point-of-Care Ultrasound: From Concept to Application. Anesthesiology 2020; 132:908.</a></li><li><a class="nounderline abstract_t">Pereira RM, Silva AJLCD, Faller J, et al. Comparative Analysis of the Collapsibility Index and Distensibility Index of the Inferior Vena Cava Through Echocardiography with Pulse Pressure Variation That Predicts Fluid Responsiveness in Surgical Patients: An Observational Controlled Trial. J Cardiothorac Vasc Anesth 2020; 34:2162.</a></li><li><a class="nounderline abstract_t">Zhang C. Does the Device Matter in Goal-Directed Fluid Therapy? Anesth Analg 2016; 123:1061.</a></li><li><a class="nounderline abstract_t">Saugel B, Thiele RH, Hapfelmeier A, Cannesson M. Technological Assessment and Objective Evaluation of Minimally Invasive and Noninvasive Cardiac Output Monitoring Systems. Anesthesiology 2020; 133:921.</a></li><li><a class="nounderline abstract_t">Fischer MO, Lemoine S, Tavernier B, et al. Individualized Fluid Management Using the Pleth Variability Index: A Randomized Clinical Trial. Anesthesiology 2020; 133:31.</a></li><li><a class="nounderline abstract_t">Kouz K, Scheeren TWL, de Backer D, Saugel B. Pulse Wave Analysis to Estimate Cardiac Output. Anesthesiology 2021; 134:119.</a></li><li><a class="nounderline abstract_t">Joosten A, Desebbe O, Suehiro K, et al. Accuracy and precision of non-invasive cardiac output monitoring devices in perioperative medicine: a systematic review and meta-analysis†. Br J Anaesth 2017; 118:298.</a></li><li><a class="nounderline abstract_t">Morgan TJ. The ideal crystalloid - what is 'balanced'? Curr Opin Crit Care 2013; 19:299.</a></li><li><a class="nounderline abstract_t">Duggan EW, Carlson K, Umpierrez GE. Perioperative Hyperglycemia Management: An Update. Anesthesiology 2017; 126:547.</a></li><li><a class="nounderline abstract_t">Bampoe S, Odor PM, Dushianthan A, et al. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database Syst Rev 2017; 9:CD004089.</a></li><li><a class="nounderline abstract_t">Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg 2015; 102:24.</a></li><li><a class="nounderline abstract_t">Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821.</a></li><li><a class="nounderline abstract_t">Sen A, Keener CM, Sileanu FE, et al. Chloride Content of Fluids Used for Large-Volume Resuscitation Is Associated With Reduced Survival. Crit Care Med 2017; 45:e146.</a></li><li><a class="nounderline abstract_t">Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90:1265.</a></li><li><a class="nounderline abstract_t">Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93:811.</a></li><li><a class="nounderline abstract_t">Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256:18.</a></li><li><a class="nounderline abstract_t">Schäfer M, Von Ungern-Sternberg BS, Wight E, Schneider MC. Isotonic fluid absorption during hysteroscopy resulting in severe hyperchloremic acidosis. Anesthesiology 2005; 103:203.</a></li><li><a class="nounderline abstract_t">Gheorghe C, Dadu R, Blot C, et al. Hyperchloremic metabolic acidosis following resuscitation of shock. Chest 2010; 138:1521.</a></li><li><a class="nounderline abstract_t">Burdett E, Dushianthan A, Bennett-Guerrero E, et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012; 12:CD004089.</a></li><li><a class="nounderline abstract_t">Orbegozo Cortés D, Rayo Bonor A, Vincent JL. Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth 2014; 112:968.</a></li><li><a class="nounderline abstract_t">Hahn RG. Changing practices of fluid therapy. Acta Anaesthesiol Scand 2017; 61:576.</a></li><li><a class="nounderline abstract_t">Pfortmueller CA, Funk GC, Reiterer C, et al. Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery: a double-blind randomised controlled study. Br J Anaesth 2018; 120:274.</a></li><li><a class="nounderline abstract_t">Boer C, Bossers SM, Koning NJ. Choice of fluid type: physiological concepts and perioperative indications. Br J Anaesth 2018; 120:384.</a></li><li><a class="nounderline abstract_t">Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566.</a></li><li><a class="nounderline abstract_t">Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018; 378:829.</a></li><li><a class="nounderline abstract_t">Self WH, Semler MW, Wanderer JP, et al. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med 2018; 378:819.</a></li><li><a class="nounderline abstract_t">Kellum JA. Abnormal saline and the history of intravenous fluids. Nat Rev Nephrol 2018; 14:358.</a></li><li><a class="nounderline abstract_t">Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol 2018; 14:541.</a></li><li><a class="nounderline abstract_t">Maheshwari K, Turan A, Makarova N, et al. Saline versus Lactated Ringer's Solution: The Saline or Lactated Ringer's (SOLAR) Trial. Anesthesiology 2020; 132:614.</a></li><li><a class="nounderline abstract_t">Kawano-Dourado L, Zampieri FG, Azevedo LCP, et al. Low- Versus High-Chloride Content Intravenous Solutions for Critically Ill and Perioperative Adult Patients: A Systematic Review and Meta-analysis. Anesth Analg 2018; 126:513.</a></li><li><a class="nounderline abstract_t">Ertmer C, Rehberg S, Van Aken H, Westphal M. Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 2009; 23:193.</a></li><li><a class="nounderline abstract_t">He H, Liu D, Ince C. Colloids and the Microcirculation. Anesth Analg 2018; 126:1747.</a></li><li><a class="nounderline abstract_t">McLean DJ, Shaw AD. Intravenous fluids: effects on renal outcomes. Br J Anaesth 2018; 120:397.</a></li><li><a class="nounderline abstract_t">Hasselgren E, Zdolsek M, Zdolsek JH, et al. Long Intravascular Persistence of 20% Albumin in Postoperative Patients. Anesth Analg 2019; 129:1232.</a></li><li><a class="nounderline abstract_t">Löffel LM, Hahn RG, Engel D, Wuethrich PY. Intraoperative Intravascular Effect of Lactated Ringer's Solution and Hyperoncotic Albumin During Hemorrhage in Cystectomy Patients. Anesth Analg 2021; 133:413.</a></li><li><a class="nounderline abstract_t">Lewis SR, Pritchard MW, Evans DJ, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 2018; 8:CD000567.</a></li><li><a class="nounderline abstract_t">Heming N, Lamothe L, Jaber S, et al. Morbidity and Mortality of Crystalloids Compared to Colloids in Critically Ill Surgical Patients: A Subgroup Analysis of a Randomized Trial. Anesthesiology 2018; 129:1149.</a></li><li><a class="nounderline abstract_t">Joosten A, Delaporte A, Ickx B, et al. Crystalloid versus Colloid for Intraoperative Goal-directed Fluid Therapy Using a Closed-loop System: A Randomized, Double-blinded, Controlled Trial in Major Abdominal Surgery. Anesthesiology 2018; 128:55.</a></li><li><a class="nounderline abstract_t">Joosten A, Delaporte A, Mortier J, et al. Long-term Impact of Crystalloid versus Colloid Solutions on Renal Function and Disability-free Survival after Major Abdominal Surgery. Anesthesiology 2019; 130:227.</a></li><li><a class="nounderline abstract_t">Reiterer C, Kabon B, Halvorson S, et al. Hemodynamic Responses to Crystalloid and Colloid Fluid Boluses during Noncardiac Surgery. Anesthesiology 2022; 136:127.</a></li><li><a class="nounderline abstract_t">Wigmore GJ, Anstey JR, St John A, et al. 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study). J Cardiothorac Vasc Anesth 2019; 33:2920.</a></li><li><a class="nounderline abstract_t">Opperer M, Poeran J, Rasul R, et al. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis. BMJ 2015; 350:h1567.</a></li><li><a class="nounderline abstract_t">Ryhammer PK, Tang M, Hoffmann-Petersen J, et al. Colloids in Cardiac Surgery-Friend or Foe? J Cardiothorac Vasc Anesth 2017; 31:1639.</a></li><li><a class="nounderline abstract_t">Kammerer T, Brettner F, Hilferink S, et al. No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial. Anesthesiology 2018; 128:67.</a></li><li><a class="nounderline abstract_t">Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; :CD007594.</a></li><li><a class="nounderline abstract_t">Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144:223.</a></li><li><a class="nounderline abstract_t">Zarbock A, Buhre W. Hydroxyethyl Starch in the Perioperative Period: Friend, Foe, or Still an Unsolved Issue? Anesth Analg 2022; 134:683.</a></li><li><a class="nounderline abstract_t">Lee MJ, Tannenbaum C, Mao G, et al. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial. Anesth Analg 2021; 133:906.</a></li><li><a class="nounderline abstract_t">McConnell M, Baisden J, Duncan AE. Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery. J Cardiothorac Vasc Anesth 2018; 32:570.</a></li><li class="breakAll">FDA calls for new warning labels on hydroxyethyl starch products. https://www.raps.org/news-and-articles/news-articles/2021/7/fda-calls-for-new-warning-labels-on-hydroxyethyl-s (Accessed on April 06, 2022).</li><li><a class="nounderline abstract_t">Tobey R, Cheng H, Gao M, et al. Postoperative Acute Kidney Injury and Blood Product Transfusion After Synthetic Colloid Use During Cardiac Surgery. J Cardiothorac Vasc Anesth 2017; 31:853.</a></li><li><a class="nounderline abstract_t">Hartog CS, Reuter D, Loesche W, et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011; 37:1725.</a></li><li><a class="nounderline abstract_t">Sacchet-Cardozo F, Stoicea N, Joseph N, et al. Con: Hetastarch Should be Avoided for Volume Expansion in Cardiac Surgery Patients. J Cardiothorac Vasc Anesth 2018; 32:576.</a></li><li><a class="nounderline abstract_t">Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103:654.</a></li><li><a class="nounderline abstract_t">Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008; 107:382.</a></li><li><a class="nounderline abstract_t">Duncan AE, Jia Y, Soltesz E, et al. Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial. Anaesthesia 2020; 75:1180.</a></li><li><a class="nounderline abstract_t">Krishnamoorthy V, Ellis AR, McLean DJ, et al. Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning. Anesth Analg 2020; 131:1193.</a></li><li><a class="nounderline abstract_t">Koponen T, Musialowicz T, Lahtinen P. Gelatin and the risk of bleeding after cardiac surgery. Acta Anaesthesiol Scand 2020; 64:1438.</a></li><li><a class="nounderline abstract_t">Thomas-Rueddel DO, Vlasakov V, Reinhart K, et al. Safety of gelatin for volume resuscitation--a systematic review and meta-analysis. Intensive Care Med 2012; 38:1134.</a></li><li><a class="nounderline abstract_t">Warkentin TE, Ning S, Lim W. Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene. N Engl J Med 2020; 383:1592.</a></li><li><a class="nounderline abstract_t">Lambert KG, Wakim JH, Lambert NE. Preoperative fluid bolus and reduction of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery. AANA J 2009; 77:110.</a></li><li><a class="nounderline abstract_t">Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118:85.</a></li><li><a class="nounderline abstract_t">Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth 2014; 112:281.</a></li><li><a class="nounderline abstract_t">Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112:635.</a></li><li><a class="nounderline abstract_t">Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg 2015; 120:389.</a></li><li><a class="nounderline abstract_t">Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247.</a></li><li><a class="nounderline abstract_t">Brandstrup B, Svensen C, Engquist A. Hemorrhage and operation cause a contraction of the extracellular space needing replacement--evidence and implications? A systematic review. Surgery 2006; 139:419.</a></li><li><a class="nounderline abstract_t">Myles PS, Andrews S, Nicholson J, et al. Contemporary Approaches to Perioperative IV Fluid Therapy. World J Surg 2017; 41:2457.</a></li><li><a class="nounderline abstract_t">Bellomo R. Noradrenaline: friend or foe? Heart Lung Circ 2003; 12 Suppl 2:S42.</a></li><li><a class="nounderline abstract_t">Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005; 95:20.</a></li><li><a class="nounderline abstract_t">Brandstrup B. Finding the Right Balance. N Engl J Med 2018; 378:2335.</a></li><li><a class="nounderline abstract_t">Rahbari NN, Zimmermann JB, Schmidt T, et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009; 96:331.</a></li><li><a class="nounderline abstract_t">Lobo SM, Ronchi LS, Oliveira NE, et al. Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high-risk surgery. Crit Care 2011; 15:R226.</a></li><li><a class="nounderline abstract_t">Mahmooth Z, Jajja MR, Maxwell D, et al. Ultrarestrictive intraoperative intravenous fluids during pancreatoduodenectomy is not associated with an increase in post-operative acute kidney injury. Am J Surg 2020; 220:264.</a></li><li><a class="nounderline abstract_t">Wuethrich PY, Burkhard FC, Thalmann GN, et al. Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology 2014; 120:365.</a></li><li><a class="nounderline abstract_t">Furrer MA, Schneider MP, Löffel LM, et al. Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: A retrospective observational cohort study. Eur J Anaesthesiol 2018; 35:641.</a></li><li><a class="nounderline abstract_t">Kampmeier TG, Ertmer C. Individualized Goal-Directed Therapy: The Challenge With the Fluids. Anesth Analg 2020; 130:596.</a></li><li><a class="nounderline abstract_t">Bundgaard-Nielsen M, Holte K, Secher NH, Kehlet H. Monitoring of peri-operative fluid administration by individualized goal-directed therapy. Acta Anaesthesiol Scand 2007; 51:331.</a></li><li><a class="nounderline abstract_t">Barthélémy R, Kindermans M, Delval P, et al. Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach. Br J Anaesth 2022; 128:236.</a></li><li><a class="nounderline abstract_t">Biais M, de Courson H, Lanchon R, et al. Mini-fluid Challenge of 100 ml of Crystalloid Predicts Fluid Responsiveness in the Operating Room. Anesthesiology 2017; 127:450.</a></li><li><a class="nounderline abstract_t">Messina A, Longhini F, Coppo C, et al. Use of the Fluid Challenge in Critically Ill Adult Patients: A Systematic Review. Anesth Analg 2017; 125:1532.</a></li><li><a class="nounderline abstract_t">Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev 2019; 12:CD012767.</a></li><li><a class="nounderline abstract_t">Chong MA, Wang Y, Berbenetz NM, McConachie I. Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis. Eur J Anaesthesiol 2018; 35:469.</a></li><li><a class="nounderline abstract_t">Kehlet H, Joshi GP. Systematic Reviews and Meta-Analyses of Randomized Controlled Trials on Perioperative Outcomes: An Urgent Need for Critical Reappraisal. Anesth Analg 2015; 121:1104.</a></li><li><a class="nounderline abstract_t">Gillies MA, Pearse R, Chew MS. Peri-operative goal-directed therapy: A definitive answer remains elusive. Eur J Anaesthesiol 2018; 35:467.</a></li><li><a class="nounderline abstract_t">Kaufmann T, Clement RP, Scheeren TWL, et al. Perioperative goal-directed therapy: A systematic review without meta-analysis. Acta Anaesthesiol Scand 2018; 62:1340.</a></li><li><a class="nounderline abstract_t">Maheshwari K, Sessler DI. Goal-directed Therapy: Why Benefit Remains Uncertain. Anesthesiology 2020; 133:5.</a></li><li><a class="nounderline abstract_t">Jessen MK, Vallentin MF, Holmberg MJ, et al. Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis. Br J Anaesth 2022; 128:416.</a></li><li><a class="nounderline abstract_t">Rollins KE, Lobo DN. Intraoperative Goal-directed Fluid Therapy in Elective Major Abdominal Surgery: A Meta-analysis of Randomized Controlled Trials. Ann Surg 2016; 263:465.</a></li><li><a class="nounderline abstract_t">Pearse RM, Harrison DA, MacDonald N, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA 2014; 311:2181.</a></li><li><a class="nounderline abstract_t">Arslan-Carlon V, Tan KS, Dalbagni G, et al. Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial. Anesthesiology 2020; 133:293.</a></li><li><a class="nounderline abstract_t">Joshi GP, Kehlet H. CON: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol? Anesth Analg 2016; 122:1261.</a></li><li><a class="nounderline abstract_t">Minto G, Scott MJ, Miller TE. Monitoring needs and goal-directed fluid therapy within an enhanced recovery program. Anesthesiol Clin 2015; 33:35.</a></li><li><a class="nounderline abstract_t">Gómez-Izquierdo JC, Feldman LS, Carli F, Baldini G. Meta-analysis of the effect of goal-directed therapy on bowel function after abdominal surgery. Br J Surg 2015; 102:577.</a></li><li><a class="nounderline abstract_t">Miller TE, Roche AM, Mythen M. Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS). Can J Anaesth 2015; 62:158.</a></li><li><a class="nounderline abstract_t">Kaufmann T, Saugel B, Scheeren TWL. Perioperative goal-directed therapy - What is the evidence? Best Pract Res Clin Anaesthesiol 2019; 33:179.</a></li><li><a class="nounderline abstract_t">Deng QW, Tan WC, Zhao BC, et al. Is goal-directed fluid therapy based on dynamic variables alone sufficient to improve clinical outcomes among patients undergoing surgery? A meta-analysis. Crit Care 2018; 22:298.</a></li><li><a class="nounderline abstract_t">Joosten A, Rinehart J, Van der Linden P, et al. Computer-assisted Individualized Hemodynamic Management Reduces Intraoperative Hypotension in Intermediate- and High-risk Surgery: A Randomized Controlled Trial. Anesthesiology 2021; 135:258.</a></li><li class="breakAll">British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP). London: NHS National Library of Health. http://www.ics.ac.uk/intensive_care_professional/standards_and_guidelines/british_consensus_guidelines_on_intravenous_fluid_therapy_for_adult_surgical_patients__giftasup__2008 (Accessed on September 18, 2009).</li><li><a class="nounderline abstract_t">Bundgaard-Nielsen M, Secher NH, Kehlet H. 'Liberal' vs. 'restrictive' perioperative fluid therapy--a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53:843.</a></li><li><a class="nounderline abstract_t">Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011; 112:1392.</a></li><li><a class="nounderline abstract_t">Lassen K. Intravenous fluid therapy. Br J Surg 2009; 96:123.</a></li><li><a class="nounderline abstract_t">Lobo DN. Fluid overload and surgical outcome: another piece in the jigsaw. Ann Surg 2009; 249:186.</a></li><li><a class="nounderline abstract_t">Hatton GE, Du RE, Wei S, et al. Positive Fluid Balance and Association with Post-Traumatic Acute Kidney Injury. J Am Coll Surg 2020; 230:190.</a></li></ol></div><div id="topicVersionRevision">Topic 14942 Version 58.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26565138" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Perioperative Fluid Utilization Variability and Association With Outcomes: Considerations for Enhanced Recovery Efforts in Sample US Surgical Populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17098724" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Wet, dry or something else?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28288059" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30138176" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Update on Perioperative Acute Kidney Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31240711" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Effect of preoperative fluid therapy on hemodynamic stability during anesthesia induction, a randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18339157" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Blood volume is normal after pre-operative overnight fasting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30238969" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fluid deficits during prolonged overnight fasting in young healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30789364" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Perioperative Fluid Therapy for Major Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19653435" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The 'third space'--fact or fiction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/596094" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Water loss by evaporation from the abdominal cavity during surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18813052" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A rational approach to perioperative fluid management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16850777" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fluid therapy for the surgical patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11818780" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Volume kinetic analysis of the distribution of 0.9% saline in conscious versus isoflurane-anesthetized sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12606911" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Isoflurane but not mechanical ventilation promotes extravascular fluid accumulation during crystalloid volume loading.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2364713" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Postoperative fluid overload: not a benign problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12393365" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pathophysiology and clinical implications of perioperative fluid excess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10334155" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Fatal postoperative pulmonary edema: pathogenesis and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983453" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effect of intraoperative fluid management on outcome after intraabdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12860760" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Mechanism of acute ascites formation after trauma resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12799335" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27673307" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16037184" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34854823" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The Relation Between Mean Arterial Pressure and Cardiac Index in Major Abdominal Surgery Patients: A Prospective Observational Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19602972" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18628220" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20543685" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fluid status and fluid responsiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24132054" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Central venous pressure cannot predict fluid-responsiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18362606" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Venous function and central venous pressure: a physiologic story.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26650057" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1812851" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Central venous pressure monitoring: clinical insights beyond the numbers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23774337" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26505575" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29136086" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intraoperative oliguria predicts acute kidney injury after major abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742967" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30916001" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29156029" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intraoperative permissive oliguria - how much is too much?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23787055" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The urine output definition of acute kidney injury is too liberal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19653436" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Monitoring fluid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17827646" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Microcirculatory function monitoring at the bedside--a view from the intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19224798" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Minimally invasive cardiac output monitoring in the perioperative setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18997528" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Using ventilation-induced plethysmographic variations to optimize patient fluid status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21508838" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : What is a fluid challenge?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26459299" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Physiological controversies and methods used to determine fluid responsiveness: a qualitative systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25391734" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Inter-device differences in monitoring for goal-directed fluid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32516148" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Using Dynamic Variables to Guide Perioperative Fluid Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22467895" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The ability of anesthesia providers to visually estimate systolic pressure variability using the "eyeball" technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27858374" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prediction of fluid responsiveness: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29077613" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pressure Waveform Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29787412" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Does Respiratory Variation in Inferior Vena Cava Diameter Predict Fluid Responsiveness in Mechanically Ventilated Patients? A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21705869" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23274783" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Validation of pulse pressure variation and corrected flow time as predictors of fluid responsiveness in patients in the prone position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20190260" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30300177" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22337956" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Rational fluid management: dissecting facts from fiction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28504996" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Stroke Volume Variation and Pulse Pressure Variation Are Not Useful for Predicting Fluid Responsiveness in Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28030449" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Hemodynamic monitoring in thoracic surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22185905" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Dynamic indices do not predict volume responsiveness in routine clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33687175" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Hemodynamic Changes via the Lung Recruitment Maneuver Can Predict Fluid Responsiveness in Stroke Volume and Arterial Pressure During One-Lung Ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18086070" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22897633" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Optimising stroke volume and oxygen delivery in abdominal aortic surgery: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25559474" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23966648" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31977521" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Perioperative Point-of-Care Ultrasound: From Concept to Application.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32217045" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Comparative Analysis of the Collapsibility Index and Distensibility Index of the Inferior Vena Cava Through Echocardiography with Pulse Pressure Variation That Predicts Fluid Responsiveness in Surgical Patients: An Observational Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27636581" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Does the Device Matter in Goal-Directed Fluid Therapy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32773696" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Technological Assessment and Objective Evaluation of Minimally Invasive and Noninvasive Cardiac Output Monitoring Systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32205547" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Individualized Fluid Management Using the Pleth Variability Index: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32914174" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pulse Wave Analysis to Estimate Cardiac Output.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28203792" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Accuracy and precision of non-invasive cardiac output monitoring devices in perioperative medicine: a systematic review and meta-analysis†.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743589" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The ideal crystalloid - what is 'balanced'?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28121636" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Perioperative Hyperglycemia Management: An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28933805" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25357011" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22470070" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27635770" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Chloride Content of Fluids Used for Large-Volume Resuscitation Is Associated With Reduced Survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10319771" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11574338" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22580944" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte®148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983474" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Isotonic fluid absorption during hysteroscopy resulting in severe hyperchloremic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21138891" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Hyperchloremic metabolic acidosis following resuscitation of shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23235602" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Perioperative buffered versus non-buffered fluid administration for surgery in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24736393" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Isotonic crystalloid solutions: a structured review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28573654" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Changing practices of fluid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29406176" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery: a double-blind randomised controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29406187" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Choice of fluid type: physiological concepts and perioperative indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23073953" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29485925" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Balanced Crystalloids versus Saline in Critically Ill Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29485926" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Balanced Crystalloids versus Saline in Noncritically Ill Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29654298" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Abnormal saline and the history of intravenous fluids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30072710" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Intravenous fluid therapy in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31977517" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Saline versus Lactated Ringer's Solution: The Saline or Lactated Ringer's (SOLAR) Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29189271" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Low- Versus High-Chloride Content Intravenous Solutions for Critically Ill and Perioperative Adult Patients: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19653439" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Relevance of non-albumin colloids in intensive care medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29099424" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Colloids and the Microcirculation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29406188" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Intravenous fluids: effects on renal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30768453" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Long Intravascular Persistence of 20% Albumin in Postoperative Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32947291" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Intraoperative Intravascular Effect of Lactated Ringer's Solution and Hyperoncotic Albumin During Hemorrhage in Cystectomy Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30073665" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Colloids versus crystalloids for fluid resuscitation in critically ill people.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30212412" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Morbidity and Mortality of Crystalloids Compared to Colloids in Critically Ill Surgical Patients: A Subgroup Analysis of a Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29068831" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Crystalloid versus Colloid for Intraoperative Goal-directed Fluid Therapy Using a Closed-loop System: A Randomized, Double-blinded, Controlled Trial in Major Abdominal Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30418217" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Long-term Impact of Crystalloid versus Colloid Solutions on Renal Function and Disability-free Survival after Major Abdominal Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34724045" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Hemodynamic Responses to Crystalloid and Colloid Fluid Boluses during Noncardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31097338" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25817299" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28372955" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Colloids in Cardiac Surgery-Friend or Foe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29064872" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20091640" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22578894" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35299209" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Hydroxyethyl Starch in the Perioperative Period: Friend, Foe, or Still an Unsolved Issue?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34406128" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174121" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174121" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28302346" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Postoperative Acute Kidney Injury and Blood Product Transfusion After Synthetic Colloid Use During Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21989733" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27692904" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Con: Hetastarch Should be Avoided for Volume Expansion in Cardiac Surgery Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16129993" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Effects of hydroxyethyl starch solutions on hemostasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18633012" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32072617" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32925340" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32735701" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Gelatin and the risk of bleeding after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22527076" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Safety of gelatin for volume resuscitation--a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33053292" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19388505" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Preoperative fluid bolus and reduction of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356162" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Consensus guidelines for the management of postoperative nausea and vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24056586" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21304149" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25565318" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15163774" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : A comparison of albumin and saline for fluid resuscitation in the intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16546507" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Hemorrhage and operation cause a contraction of the extracellular space needing replacement--evidence and implications? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28484814" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Contemporary Approaches to Perioperative IV Fluid Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16352145" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Noradrenaline: friend or foe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15531622" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Kidney dysfunction in the postoperative period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742973" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Finding the Right Balance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19283742" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21943111" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high-risk surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32234242" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Ultrarestrictive intraoperative intravenous fluids during pancreatoduodenectomy is not associated with an increase in post-operative acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23887199" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29652680" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: A retrospective observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32068587" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Individualized Goal-Directed Therapy: The Challenge With the Fluids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17390421" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Monitoring of peri-operative fluid administration by individualized goal-directed therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34895718" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28640019" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Mini-fluid Challenge of 100 ml of Crystalloid Predicts Fluid Responsiveness in the Operating Room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28514324" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Use of the Fluid Challenge in Critically Ill Adult Patients: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31829446" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29369117" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26378707" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Systematic Reviews and Meta-Analyses of Randomized Controlled Trials on Perioperative Outcomes: An Urgent Need for Critical Reappraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29870473" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Peri-operative goal-directed therapy: A definitive answer remains elusive.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29978454" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Perioperative goal-directed therapy: A systematic review without meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32358252" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Goal-directed Therapy: Why Benefit Remains Uncertain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34916049" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26445470" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Intraoperative Goal-directed Fluid Therapy in Elective Major Abdominal Surgery: A Meta-analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24842135" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32472804" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27101489" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : CON: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25701927" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Monitoring needs and goal-directed fluid therapy within an enhanced recovery program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25759947" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Meta-analysis of the effect of goal-directed therapy on bowel function after abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25391735" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31582097" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Perioperative goal-directed therapy - What is the evidence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30428928" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Is goal-directed fluid therapy based on dynamic variables alone sufficient to improve clinical outcomes among patients undergoing surgery? A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33951140" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Computer-assisted Individualized Hemodynamic Management Reduces Intraoperative Hypotension in Intermediate- and High-risk Surgery: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33951140" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Computer-assisted Individualized Hemodynamic Management Reduces Intraoperative Hypotension in Intermediate- and High-risk Surgery: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19519723" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : 'Liberal' vs. 'restrictive' perioperative fluid therapy--a critical assessment of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20966436" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19160362" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Intravenous fluid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19212168" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Fluid overload and surgical outcome: another piece in the jigsaw.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31733328" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Positive Fluid Balance and Association with Post-Traumatic Acute Kidney Injury.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
